Edition:
United States

Laboratory Corporation of America Holdings (LH.N)

LH.N on New York Stock Exchange

143.29USD
21 Apr 2017
Change (% chg)

-- (--)
Prev Close
$143.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
201,017
52-wk High
$146.62
52-wk Low
$118.73

LH.N

Chart for LH.N

About

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $14,677.19
Shares Outstanding(Mil.): 102.43
Dividend: --
Yield (%): --

Financials

  LH.N Industry Sector
P/E (TTM): 20.48 33.05 29.95
EPS (TTM): 7.00 -- --
ROI: 5.91 5.61 13.21
ROE: 14.01 8.75 14.38

BRIEF-Labcorp - CEO David P. King's total compensation in 2016 was $10.85 million

March 31 Laboratory Corporation Of America Holdings

Mar 31 2017

BRIEF-Laboratory Corporation Of America Q4 adjusted EPS $2.15

Feb 16 Laboratory Corporation Of America Holdings :

Feb 16 2017

LabCorp explores acquisition of clinical trials firm PPD -sources

Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract researcher Pharmaceutical Product Development LLC (PPD) for more than $8 billion, including debt, people familiar with the matter said on Friday.

Feb 03 2017

Exclusive: LabCorp explores acquisition of clinical trials firm PPD - sources

Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract researcher Pharmaceutical Product Development LLC (PPD) for more than $8 billion, including debt, people familiar with the matter said on Friday.

Feb 03 2017

BRIEF-Laboratory Corporation of America reports Q3 EPS $1.71

Oct 26 Laboratory Corporation Of America Holdings

Oct 26 2016

More From Around the Web

Earnings vs. Estimates